J&J CFO Joseph Wolk on Q2 earnings beat: We're in a very strong position for second half of 2023

J&J CFO Joseph Wolk on Q2 earnings beat: We're in a very strong position for second half of 2023Подробнее

J&J CFO Joseph Wolk on Q2 earnings beat: Very pleased with the performance overallПодробнее

J&J CFO Joe Wolk: Anticipating 3% operational growth in 2025 despite 'significant' headwindsПодробнее

J&J CFO Joseph Wolk on Q3 results: Earnings beat driven by pharmaceuticalsПодробнее

J&J CFO Joseph Wolk on Q4 earnings beat: Near- and long-term looks very strong at the companyПодробнее

Johnson & Johnson CFO on Q2 earnings beatПодробнее

Johnson & Johnson CFO on Q2 earnings, litigation, product pipelineПодробнее

J&J CFO Joseph Wolk on Q1 earningsПодробнее

Johnson & Johnson CFO Joseph Wolk on Q4 earnings beatПодробнее

Johnson & Johnson CFO breaks down mixed earnings report, full-year guidanceПодробнее

Great scientific innovation continues to produce great financial results for our company: J&J CFOПодробнее

Johnson & Johnson CFO Joseph Wolk on Q3 results: Very well-positioned into 2024 and beyondПодробнее

J&J CFO on Q1 Earnings, Forecast and Product PipelineПодробнее

Joe Wolk, CFO, Johnson & JohnsonПодробнее

Johnson & Johnson CFO Joseph Wolk on supply challenges of Tylenol, MotrinПодробнее

Procter & Gamble CFO on Q2 earnings beat and raised outlookПодробнее

PepsiCo CFO Hugh Johnston on Q2 earnings: We're driving margins through productivityПодробнее

Zoom CFO Kelly Steckelberg on Q2 earnings, return to work policyПодробнее